Start-up Village

28.05.13Intro-Micro L.L.C.

Pocket-size CES-analyzer of volatile bio-marker molecules for a continuous non-invasive medical diagnostics

Main advantages

1.Individual biochemical gas analyzer in dimensions of cellular phone

2.Portfolio of patents in USA, Japan, China, Germany, France, UK, Russia

3.May become Next Great Global Gadget (1M – 1B units at retail price < $1K)

Investment need:

$0.3M – Round A, $2M – Round B

Project Stage

Proof of concept, prototyping

Project Leader

Alexander Tsyganov, C.E.O. for Intro-Micro LLC

• Small and cost-effective gas analyzer based on the patented method of Collisional Electron Spectroscopy (CES)

• Non-invasive continuous monitoring and diagnostics of human metabolism- Sensitivity better 1 ppm- Operates at atmospheric pressure- Pocket-size, small weight, battery operation- Price below $1,000

• Mobile data transmission, bio-informatics and individual genomics used for preventive medicine

• CES-detectors sales & services (B2C and B2B) • Prototype under development and investigation

Problem: clear gap in medicine - lack of continuous monitoring of individual metabolism (basis of preventive healthcare)Solution: non-invasive diagnostics of volatile bio-markers emitted by human body using our pocket-size CES-detector

• Growing number of diseases can be diagnosed by “sniffing” the patient: lung cancer, tuberculosis, COPD, asthma, diabetes, kidney disease, mammary cancer, Crohn’s disease, ulcerative colitis, etc.

• Each individual has a genetic “gasprint”. Link of genomics to metabolomics

• Continuous control of the nutrition and lifestyle, metabolic scoring

• 10 times smaller & cheaper than traditional gas analyzing competitors.• Smartphone-based m-Health solutions (ALiveCor, LifeWatch, etc.) cannot sniff. • Key patent portfolio on CES technology: US 7309992, Japan 4408810, Germany, France and UK

EP1557667, China ZL200380106502.2, Russia 2217739.

Smith Detection Sabre 4000: 3 kg, 36,3 x 11 x 13 cm , $28,934 MSRP

CES-based Health Monitor: 30 g, 1x1x1 cm, < $999 MSRP

Market of m-Health• “Intelligent accessories that focus on training, weight management

and healthcare monitoring of chronic disease…”- Projected to reach 110 million units in 2017, up from 10 million in

2012*• Total mHealth market projected to grow to $23B by 2017**, from

$1.3B in 2012 ($6.6B for devices)

*source: http://www.rcrwireless.com/article/20121126/devices/ericssons-view-impact-becoming-wireless-forecasts-9-3-b-mobile-subs-2018/

**source: http://www.rcrwireless.com/americas/20120906/mobile-content/mhealth-smart-wireless-accessories-reach-110-million-units-2017

Competitive advantage: disruptive technology + high barrier to entry

• Alexander Tsyganov – team leader, M.S. (physics) - electronics design - Patent co-inventor

• Nataliya Luneva, Medicine Doctor Degree, Professor of Dentistry and Medicine Technologies Faculty of SPbSU - medical research leader

• Anatoly Kudryavtsev, Ph.D. (physics), SPbSU, plasma simulation - Patent co-inventor

• George Panasyuk, Ph.D. (physics), research scientist at WP AFB Research Lab., Ohio 45433, USA – software design

• George Paskalov, Ph.D. (physics), CEO at Plasma Microsystems L.L.C., Torrance CA 90503, USA and other hi-tech companies - device design

• Andrey Rubashkin, Ph.D. (physics), research scientist at Cytology Institute RAS – software design

• Victoria Mironenko, Ph.D. (biology) - marketing and finances• Dmitry Zashcherinskiy, M.S. (economics), business-angel, serial

entrepreneur - business development• Mikhail Budilov, attorney at law - lawyer advisor • Alex Mushkin, M.S. (engineering) - CEO of our USA company

All necessary main competences are “on board”

The Team

• Invested to-date - $0.1M (patenting and start of prototype development)• Round A investments situation: 25% company’s share is negotiated with

business-angels to invest $0.3M for + we are eligible to apply for a matching (1:3) Skolkovo grant $0.9M for proof of concept and experimental prototype of CES-detector. Company’s estimated valuation is $2.1M

• For the next Round B we are seeking for $2M in equity investment addressed to development of commercial prototype and clinical studies of diagnostics methods based on volatile biomarker molecules detection using CES-detectors. Expected share of investor – minority

• We are also looking for a young person (investor + our director of business development, IR and GR). Moving our global humanistic project, he/she will be welcomed and able to enter all high societies worldwide!

Contact: Alexander Tsyganov, C.E.O. of Intro-Micro L.L.C.Intro-micro@mail.ru phone: (+7) 812 9252534

Investment offer / our needs